Home > Annual Financials > LAURUS LABS

LAURUS LABS Financial Statement Analysis
[BOM: 540222|NSE : LAURUSLABS]

The Revenues of LAURUS LABS have increased by 10.18% YoY .
The Earnings Per Share (EPS) of LAURUS LABS has increased by 126.62 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

LAURUS LABS Last 5 Annual Financial Results
[BOM: 540222|NSE : LAURUSLABS]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹5,554 Cr₹5,041 Cr₹6,041 Cr₹4,936 Cr₹4,814 Cr
Expenses ₹4,499 Cr₹4,263 Cr₹4,448 Cr₹3,513 Cr₹3,263 Cr
Operating Profit (Excl OI) ₹1,055 Cr₹778 Cr₹1,592 Cr₹1,422 Cr₹1,551 Cr
Other Income ₹75 Cr₹26 Cr₹6.00 Cr₹15 Cr₹24 Cr
Interest ₹216 Cr₹183 Cr₹165 Cr₹102 Cr₹68 Cr
Depreciation ₹430 Cr₹385 Cr₹324 Cr₹251 Cr₹205 Cr
Profit Before Tax ₹484 Cr₹236 Cr₹1,109 Cr₹1,084 Cr₹1,301 Cr
Profit After Tax ₹354 Cr₹168 Cr₹797 Cr₹832 Cr₹984 Cr
Consolidated Net Profit ₹358 Cr₹158 Cr₹785 Cr₹828 Cr₹984 Cr
Earnings Per Share (Rs)₹6.64₹2.93₹14.56₹15.40₹18.33
PAT Margin (%)6.383.3413.1916.8720.44
ROE(%)8.304.1521.6328.0545.15
ROCE(%)10.166.6422.9725.9739.82
Total Debt/Equity(x)0.610.610.490.520.56

Key Financials

Market Cap : ₹ 40,254.2 Cr
Revenue (TTM) : ₹ 5,554.0 Cr
Net Profit(TTM) : ₹ 354.4 Cr
EPS (TTM) : ₹ 6.6
P/E (TTM) : 113.6

Industry Peers & Returns1W1M1Y
LAURUS LABS 11.4% 22% 71.1%
SUN PHARMACEUTICAL INDUSTRIES -0.2% -0.5% 10.7%
DIVIS LABORATORIES 4% 4.8% 50.5%
CIPLA 0.4% 3.1% 1.6%
TORRENT PHARMACEUTICALS 5.9% 9.1% 23%
DR REDDYS LABORATORIES -4.8% 2.2% 2.9%
MANKIND PHARMA -0.9% -5.2% 8.7%
ZYDUS LIFESCIENCES 2.7% 7.8% -6.5%
LUPIN 1.4% 0.1% 22.3%


LAURUS LABS Revenues
[BOM: 540222|NSE : LAURUSLABS]

Y-o-Y

10.18 %

5 Yr CAGR

3.64 %

Years Revenues % Change
Mar2025 ₹5,554 Cr
10.18
Mar2024 ₹5,041 Cr
-16.55
Mar2023 ₹6,041 Cr
22.39
Mar2022 ₹4,936 Cr
2.54
Mar2021 ₹4,814 Cr -


LAURUS LABS Operating Profit
[BOM: 540222|NSE : LAURUSLABS]

Y-o-Y

35.73 %

5 Yr CAGR

-9.17 %

Years Operating Profit % Change
Mar2025 ₹1,055 Cr
35.73
Mar2024 ₹778 Cr
-51.17
Mar2023 ₹1,592 Cr
11.93
Mar2022 ₹1,422 Cr
-8.27
Mar2021 ₹1,551 Cr -

Operating Margins
Y-o-Y

23.22 %

5 Yr CAGR

-12.37 %

Years Operating Margin% % Change
Mar2025 19%
23.22
Mar2024 15.42%
-41.50
Mar2023 26.36%
-8.54
Mar2022 28.82%
-10.55
Mar2021 32.22% -

LAURUS LABS Profit After Tax
[BOM: 540222|NSE : LAURUSLABS]

Y-o-Y

127.25 %

5 Yr CAGR

-22.31 %

Years Profit After Tax % Change
Mar2025 ₹358 Cr
127.25
Mar2024 ₹158 Cr
-79.90
Mar2023 ₹785 Cr
-5.20
Mar2022 ₹828 Cr
-15.87
Mar2021 ₹984 Cr -

PAT Margins
Y-o-Y

91.02 %

5 Yr CAGR

-25.25 %

Years PAT Margin(%) % Change
Mar2025 6.38 %
91.02
Mar2024 3.34 %
-74.68
Mar2023 13.19 %
-21.81
Mar2022 16.87 %
-17.47
Mar2021 20.44 % -

LAURUS LABS Earnings Per Share (EPS)
[BOM: 540222|NSE : LAURUSLABS]

Y-o-Y

126.62 %

5 Yr CAGR

-22.42 %

Years EPS % Change
Mar2025 ₹6.64
126.62
Mar2024 ₹2.93
-79.88
Mar2023 ₹15
-5.45
Mar2022 ₹15
-15.98
Mar2021 ₹18 -

LAURUS LABS Return on Capital Employed (ROCE)
[BOM: 540222|NSE : LAURUSLABS]

Y-o-Y

53.01 %

5 Yr CAGR

-28.93 %

Years ROCE % Change
Mar2025 10.16%
53.01
Mar2024 6.64%
-71.09
Mar2023 22.97%
-11.55
Mar2022 25.97%
-34.78
Mar2021 39.82% -

LAURUS LABS Share Price vs Sensex

Current Share Price : ₹746.0
Current MarketCap: ₹ 40,254.2 Cr
Updated EOD on :Jul 01,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
LAURUS LABS

11.4%

22%

71.1%

SENSEX

2%

2.8%

6.4%

LAURUS LABS related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE LARGEMIDCAP 4.5% 7.2% 8.3%
BSE 500 SHARIAH 4.3% 4.3% 1.1%
BSE 250 SMALLCAP INDEX 3.1% 5.1% 2.4%
NSE Indices1W1M1Y
NIFTY MIDSMALL HEALTHCARE 3.5% 5.1% 23.1%
NIFTY SMALLCAP 250 3.4% 5.5% 3.9%
NIFTY SMALLCAP 100 3.3% 6.6% 4.2%
NIFTY SMALLCAP 50 3.1% 7.3% 7.3%
NIFTY 500 EQUAL WEIGHT 2.7% 3.7% 3.4%

You may also like the below Video Courses


FAQ about LAURUS LABS Financials


How the annual revenues of LAURUS LABS have changed ?

The Revenues of LAURUS LABS have increased by 10.18% YoY .

How the Earnings per Share (EPS) of LAURUS LABS have changed?

The Earnings Per Share (EPS) of LAURUS LABS has increased by 126.62 % YoY .